DeFronzo 2009)
New Drugs on the Block: Dietary Management and Nutritional Considerations During the Use of Anti-Obesity Medication
El ajuste post hoc para HbA1C y otros factores de riesgo renal tradicionales no tuvo una influencia importante en el beneficio renal con liraglutida, semaglutida o dulaglutida en los CVOT, ni hubo diferencias en el control glucmico en el estudio AWARD-766
The samples were stained with primary antibody, mouse monoclonal anti-keratin 20 (Abcam, ab854, 1:200) and secondary antibody, Alexa Fluor 647 donkey anti-mouse IgG (Invitrogen, A-31571, 1:1,000), then further stained with Alexa Fluor 555 Phalloidin (ThermoFisher, A34055, 1:200) and 4,6-diamidino-2-phenylindole (DAPI) (ThermoFisher, D1306, 1:1,000)
Critical mechanistic studies by Heffernan et al